-
Vaccines, value investing and UK stocks
Opinion Vaccines promise a return to normal life. And that bodes well for “value” stocks, says Merryn Somerset Webb – and for the UK market in particular.
Opinion -
Are value stocks finally back for good?
Advice The Covid-19 vaccine might give value investors the lift they’ve been waiting for, says John Stepek. And the UK is a good hunting ground.
Advice -
This week’s rally in value stocks is just the beginning
Opinion The arrival of a vaccine this week saw huge gains in the markets and investors switching out of big-tech growth stocks and into “value” stocks in more traditional businesses. It’s a switch that’s likely to last, says John Stepek. Here’s why.
Opinion -
What is value investing?
Tutorials Value investing is probably the purest form of contrarian investing out there, says John Stepek. But what exactly is it, and how do you go about it?
Tutorials -
Could the Covid crisis hold a silver lining for cheap value stocks?
Advice Value investing strategies have had a dreadful six months – but the crisis could be a catalyst for them to turn around.
Advice -
We could be at a pivotal point in the growth/value cycle
Opinion Growth stocks have been on an extraordinary run as central banks have inflated markets. But as economies shift from recession to growth, value will win out, says Merryn Somerset Webb.
Opinion -
Cliff Asness: value investors should stick to their guns
Analysis Value investors need to stick to their process, says Cliff Asness, co-founder of AQR Capital Management, even though that’s difficult.
Analysis
1
2